Stemson Therapeutics announced today the closing of a DCVC Bio-led $15 million Series A financing to advance development of Stemson’s proprietary therapeutic solution to cure hair loss. Genoa Ventures, AbbVie Ventures and other investors join in supporting Stemson’s efforts to restore human hair growth with a novel cell regeneration technology using the patient’s own cells to generate new hair follicles.
Read MoreCongratulations to co-Founders Lena Wu, PhD, CEO, and Erik Gentalen, CTO, and the Intabio team on its acquisition by SCIEX. Genoa is privileged to have been partners in your journey from the beginning!
Read More